Daily Edition2026-08-25
Stories ready18published in this edition
Domains covered3sections represented
Source work4668manifests read into the edition
Agent-readable2018records available through MCP
Daily edition

2026-08-25 edition

Articles, claim-of-the-day context, and the agent-readable evidence layer for this Hanging Context edition.

Economics, Business & Work

FDA Extends Review Timeline for Capricor Deramiocel Application

The FDA has delayed its decision on Capricor Therapeutics' Deramiocel until November 2026 to review new clinical data regarding upper limb function in Duchenne muscular dystrophy patients.

Gate: passed - MCP servable: 207/470 - Story 24 of 24